Free Trial

Alexander's Q4 2024 Earnings Report

Alexander's logo
$209.35 -1.73 (-0.82%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alexander's EPS Results

Actual EPS
$4.06
Consensus EPS
$3.71
Beat/Miss
Beat by +$0.35
One Year Ago EPS
N/A

Alexander's Revenue Results

Actual Revenue
N/A
Expected Revenue
$55.20 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Alexander's Announcement Details

Quarter
Q4 2024
Time
Before Market Opens

Conference Call Resources

Remove Ads

Alexander's Earnings Headlines

ALX Oncology price target lowered to $1.50 from $3 at Stifel
While Markets Slide, These "Genesis Cog" Trades Are Up Double-Digits
While most investors are struggling in today's volatile market, a small group of traders are quietly booking consistent gains. Just last week, our Genesis Cog subscribers captured an 11.51% gain shorting JEF, another 8.57% on CAKE, and 4.78% on RJF—all while the broader indexes continued their downward trend.
2ALX : Insights into Alexander's Q4 Earnings
Alexander's reports Q4 results
See More Alexander's Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alexander's? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alexander's and other key companies, straight to your email.

About Alexander's

Alexander's (NYSE:ALX) (NYSE: ALX) is a real estate investment trust (REIT), incorporated in Delaware, engaged in leasing, managing, developing and redeveloping its properties. All references to we, us, our, Company and Alexander's refer to Alexander's, Inc. and its consolidated subsidiaries. We are managed by, and our properties are leased and developed by, Vornado Realty Trust (Vornado) (NYSE: VNO). We have five properties in New York City.

View Alexander's Profile

More Earnings Resources from MarketBeat